In 1998, a similar, privately funded quest was launched by the American researcher Craig Venter, and his firm Celera Genomics.
En 1998, foi presentado un proxecto similar ao PXH público pero de financiamento privado polo investigador norteamericano Craig Venter e a súa compañía Celera Genomics.